关于“肾细胞癌患者的疫苗治疗”的编辑评论 - Suppr

Suppr

超能文献

Editorial comment on: Vaccine therapy in patients with renal cell carcinoma.

作者信息

Clark Peter E

出版信息

Eur Urol. 2009 Jun;55(6):1343-4. doi: 10.1016/j.eururo.2009.01.045. Epub 2009 Jan 30.

DOI:10.1016/j.eururo.2009.01.045

PMID:19201523

Abstract

摘要

相似文献

Editorial comment on: Vaccine therapy in patients with renal cell carcinoma.

Eur Urol. 2009 Jun;55(6):1343-4. doi: 10.1016/j.eururo.2009.01.045. Epub 2009 Jan 30.

Editorial comment on: Vaccine therapy in patients with renal cell carcinoma.

Eur Urol. 2009 Jun;55(6):1342-3. doi: 10.1016/j.eururo.2009.01.044. Epub 2009 Jan 30.

Vaccine therapy in patients with renal cell carcinoma.

Eur Urol. 2009 Jun;55(6):1333-42. doi: 10.1016/j.eururo.2009.01.043. Epub 2009 Jan 30.

Active and passive immunotherapy: vaccines and antibodies.

BJU Int. 2007 May;99(5 Pt B):1301-4. doi: 10.1111/j.1464-410X.2007.06835.x.

High-dose interleukin-2 in metastatic renal cell carcinoma.

J Clin Oncol. 2005 Sep 20;23(27):6797-8; author reply 6798-9. doi: 10.1200/JCO.2005.02.1709.

Editorial comment on: prognosis of Japanese metastatic renal cell carcinoma patients in the cytokine era: a cooperative group report of 1463 patients.

Eur Urol. 2010 Feb;57(2):325-6. doi: 10.1016/j.eururo.2008.12.027. Epub 2009 Jan 3.

The role of cytoreductive nephrectomy in the era of molecular targeted therapy.

Int J Urol. 2009 Mar;16(3):227-33. doi: 10.1111/j.1442-2042.2008.02245.x. Epub 2009 Feb 4.

Immunotherapy and prognostic factors.

J Clin Oncol. 2006 Sep 1;24(25):4218-9; author reply 4219-20. doi: 10.1200/JCO.2006.07.4211.

New therapeutic developments in renal cell cancer.

Crit Rev Oncol Hematol. 2009 Jan;69(1):56-63. doi: 10.1016/j.critrevonc.2008.07.007. Epub 2008 Aug 26.

Adjuvant therapy of renal cell carcinoma with active-specific-immunotherapy (ASI) using autologous tumor vaccine.

Anticancer Res. 1997 Jul-Aug;17(4B):2879-82.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Editorial comment on: Vaccine therapy in patients with renal cell carcinoma.

Eur Urol. 2009 Jun;55(6):1343-4. doi: 10.1016/j.eururo.2009.01.045. Epub 2009 Jan 30.

Editorial comment on: Vaccine therapy in patients with renal cell carcinoma.

Eur Urol. 2009 Jun;55(6):1342-3. doi: 10.1016/j.eururo.2009.01.044. Epub 2009 Jan 30.

Vaccine therapy in patients with renal cell carcinoma.

Eur Urol. 2009 Jun;55(6):1333-42. doi: 10.1016/j.eururo.2009.01.043. Epub 2009 Jan 30.

Active and passive immunotherapy: vaccines and antibodies.

BJU Int. 2007 May;99(5 Pt B):1301-4. doi: 10.1111/j.1464-410X.2007.06835.x.

High-dose interleukin-2 in metastatic renal cell carcinoma.

J Clin Oncol. 2005 Sep 20;23(27):6797-8; author reply 6798-9. doi: 10.1200/JCO.2005.02.1709.

Editorial comment on: prognosis of Japanese metastatic renal cell carcinoma patients in the cytokine era: a cooperative group report of 1463 patients.

Eur Urol. 2010 Feb;57(2):325-6. doi: 10.1016/j.eururo.2008.12.027. Epub 2009 Jan 3.

The role of cytoreductive nephrectomy in the era of molecular targeted therapy.

Int J Urol. 2009 Mar;16(3):227-33. doi: 10.1111/j.1442-2042.2008.02245.x. Epub 2009 Feb 4.

Immunotherapy and prognostic factors.

J Clin Oncol. 2006 Sep 1;24(25):4218-9; author reply 4219-20. doi: 10.1200/JCO.2006.07.4211.

New therapeutic developments in renal cell cancer.

Crit Rev Oncol Hematol. 2009 Jan;69(1):56-63. doi: 10.1016/j.critrevonc.2008.07.007. Epub 2008 Aug 26.

Adjuvant therapy of renal cell carcinoma with active-specific-immunotherapy (ASI) using autologous tumor vaccine.

Anticancer Res. 1997 Jul-Aug;17(4B):2879-82.